drugset / Trial / NCT01119677

A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers

NCT01119677

Phase 1 Completed 120 enrolled Biogen
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective of the study is to determine whether titration of Avonex reduces the severity of flu-like symptoms (FLS). Secondary objectives of this study are to determine whether titration of Avonex reduces the incidence of FLS and to evaluate the overall safety and tolerability of Avonex intramuscular (IM) injections.

Timeline

Start
2010-05-05
Primary completion
2010-10-23
Completion
2010-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon beta-1a Protein / enzyme biologic 30 ug Intramuscular

Indications

No indication recorded.